IFFAT AHMED: Open Payments
NPI 1063668192 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$83,146 in 234 payments from 14 companies in 2025. Trend: 2023 $2,626 · 2024 $98,007 · 2025 $83,146
Speaker / faculty: $62,475Travel & lodging: $9,062Consulting: $8,050Food & beverage: $3,559
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 129 | $79,139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $1,747 |
| ABBVIE INC. | 25 | $581 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $480 |
| Novo Nordisk Inc | 17 | $376 |
| Axsome Therapeutics, Inc. | 11 | $228 |
| Currax Pharmaceuticals LLC | 18 | $146 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Aimmune Therapeutics, Inc. | 4 | $90 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $88 |
Products named: MOUNJARO, Kerendia, JARDIANCE, Wegovy, Sunosi, QULIPTA, VRAYLAR, ZEPBOUND.
Industry payments across IL — which companies pay providers there.
